Odyssey Health (ODYY) Cash from Investing Activities (2016 - 2025)

Odyssey Health's (ODYY) quarterly Cash from Investing Activities came in at $69787.0 in Q3 2025, down 93.02% quarter-over-quarter from $1.0 million in Q1 2024.

Odyssey Health (ODYY) Cash from Investing Activities (2016 - 2025) Analysis & Trends

Odyssey Health's Cash from Investing Activities history runs 5 years deep, the most recent figure standing at $69787.0 for Q3 2025.

  • On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to $69787.0 in Q3 2025; TTM through Jul 2025 was $69787.0, a 93.02% decrease from a year earlier, with the FY2025 full-year figure at $69787.0, down 93.02% from the prior year.
  • Cash from Investing Activities fell to $69787.0 in Q3 2025 per ODYY's latest filing, from $1.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $1.0 million in Q1 2024 and bottomed at -$45220.0 in Q1 2022.
  • The 4-year median for Cash from Investing Activities is -$2023.0 (2023), against an average of $202901.2.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -185.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -475.32 Mn
10 Odyssey Health 1.08 Mn 782,508.17 - -

Historic Data

Download Data
DateValue
Jul 31, 2025 69,787.00
Jul 31, 2025 69,787.00
Jan 31, 2024 1.00 Mn
Jan 31, 2024 1.00 Mn
Jul 31, 2023 -2,023.00
Jul 31, 2023 -2,023.00
Oct 31, 2022 -8,038.00
Oct 31, 2022 -8,038.00
Jan 31, 2022 -45,220.00
Jan 31, 2022 -45,220.00
Jul 31, 2016 -3,310.00
Jul 31, 2016 -3,310.00